Class Action Filed Against Nano-X Imaging for Misleading Investors
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 4 days ago
0mins
Source: PRnewswire
- Class Action Initiated: Robbins LLP has announced a class action lawsuit on behalf of investors who purchased Nano-X Imaging Ltd. (NASDAQ:NNOX) securities between March 31, 2025, and April 17, 2026, alleging that the company misled investors regarding its manufacturing operations and financial condition.
- Allegations of Financial Misrepresentation: The complaint claims that during the class period, Nano-X overstated operational efficiencies and product demand, while in reality, its production was poorly aligned with market needs, leading to significantly increased operating expenses and cash burn.
- Restructuring and Losses: On April 20, 2026, Nano-X reported a Q4 2025 net loss of $33.4 million, including a $17.5 million impairment charge due to restructuring at its Korean chip manufacturing facility, indicating a necessary shift to a more efficient outsourced production model.
- Stock Price Plummet: Following the financial report, Nano-X's stock price fell by $0.695, or 24.39%, closing at $2.155, reflecting market concerns over the company's financial health and a sharp decline in investor confidence.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy NNOX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on NNOX
Wall Street analysts forecast NNOX stock price to rise
2 Analyst Rating
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.730
Low
7.00
Averages
7.00
High
7.00
Current: 1.730
Low
7.00
Averages
7.00
High
7.00
About NNOX
Nano-X Imaging Ltd is an Israel-based company that develops a digital X-ray source enabling a cost reduction of imaging systems.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Class Action Notice: The Gross Law Firm has issued a notice to shareholders of Nano-X Imaging Ltd. (NASDAQ: NNOX), encouraging those who purchased shares during the class period from March 31, 2025, to April 17, 2026, to contact the firm regarding possible lead plaintiff appointment for potential recovery.
- Allegations Overview: The complaint alleges that during the class period, defendants made materially false and misleading statements, failing to disclose that Nano-X's production operations were misaligned with product demand, resulting in significantly increased operating expenses and cash burn, thus raising the likelihood of disruptive remedial measures.
- Registration Deadline: Shareholders must register for the class action by August 11, 2026, and should not delay in doing so to secure their rights, with registration providing access to portfolio monitoring software for case status updates.
- Law Firm Credentials: The Gross Law Firm is a nationally recognized class action law firm committed to protecting investors' rights who have suffered losses due to deceit and illegal business practices, emphasizing the importance of corporate accountability and responsible business conduct.
See More
- ADMA Class Action: The class action lawsuit against ADMA Biologics, Inc. alleges that the company made materially false or misleading statements between August 9, 2024, and March 25, 2026, leading to investor losses, with a deadline of August 10, 2026, for investors to apply as lead plaintiffs to protect their rights.
- ERAS Legal Action: Similarly, the class action lawsuit against Erasca, Inc. claims that the company failed to disclose material facts from January 14, 2025, to April 26, 2026, and investors who purchased shares during this period and suffered losses are encouraged to contact legal counsel before the August 10, 2026 deadline.
- NNOX Lawsuit Details: The class action against Nano-X Imaging Ltd. alleges that the company made false statements regarding operational efficiency and cash burn from March 31, 2025, to April 17, 2026, with affected investors needing to apply as lead plaintiffs by August 11, 2026.
- Law Firm Background: Holzer & Holzer, LLC, a top-rated securities litigation firm, has been dedicated to representing shareholders since 2000, recovering hundreds of millions for investors affected by fraud, emphasizing its commitment to vigorous legal representation.
See More
- BitGo Lawsuit Overview: BitGo Holdings, Inc. (NYSE:BTGO) faces a class action lawsuit for the period from January 22, 2026, to May 13, 2026, due to failure to disclose the impact of declining digital asset prices on its financial performance, with a lead plaintiff deadline of August 7, 2026.
- Erasca Lawsuit Details: Erasca, Inc. (NASDAQ:ERAS) is involved in a class action lawsuit for the period from January 14, 2025, to April 26, 2026, alleging improper comparisons in preclinical data that risked patent protections, with a lead plaintiff deadline of August 10, 2026.
- Nano-X Lawsuit Issues: Nano-X Imaging Ltd. (NASDAQ:NNOX) faces a class action lawsuit for the period from March 31, 2025, to April 17, 2026, due to overstated operational efficiency and product demand, leading to increased operating expenses and cash burn, with a lead plaintiff deadline of August 11, 2026.
- Microsoft Lawsuit Background: Microsoft Corporation (NASDAQ:MSFT) is involved in a class action lawsuit for the period from May 1, 2025, to January 28, 2026, for failing to disclose multiple issues with its Copilot product line, resulting in a decline in market share, with a lead plaintiff deadline of August 11, 2026.
See More
- Class Action Initiated: Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Nano-X Imaging Ltd. aimed at recovering damages for investors who purchased securities between March 31, 2025, and April 17, 2026, highlighting potential legal liabilities for the company.
- Allegations of False Statements: The complaint alleges that during the class period, defendants made materially false and misleading statements and failed to disclose the true state of the company's business and prospects, which may have led to investor losses.
- Opportunity for Investor Participation: Affected investors are encouraged to apply to be lead plaintiffs by August 11, 2026, indicating that the legal process provides an avenue for investors to participate and recover losses.
- No-Cost Legal Services: The law firm operates on a contingency fee basis, meaning they will only charge fees if they successfully recover funds, thereby reducing the legal costs for investors.
See More
- Lawsuit Background: Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against Nano-X Imaging, alleging violations of federal securities laws between March 31, 2025, and April 17, 2026, seeking to recover damages for investors.
- False Statements Allegations: The complaint claims that Nano-X executives made materially false and misleading statements during the class period, overstating operational efficiencies and product demand, which misled investors about the company's prospects.
- Financial Impact: It highlights that Nano-X faced significant misalignment between production and demand, resulting in increased operating expenses and cash burn, raising the likelihood of disruptive restructuring measures.
- Investor Action: Affected investors are encouraged to apply as lead plaintiffs by August 11, 2026, to participate in potential recovery, with the law firm operating on a contingency fee basis, only charging if successful.
See More
- Executive Liability Lawsuit: Nano-X Imaging's CEO Erez Meltzer and CFO Ran Daniel are facing a securities class action due to a reported $33.4 million net loss in Q4 2026, highlighting significant governance risks within the company.
- Stock Price Plunge: Following the April 20, 2026 disclosure of a $17.5 million impairment charge and manufacturing restructuring, Nano-X's shares fell by $0.695, or 24.39%, indicating market concerns regarding the company's financial health.
- Legal Framework: Under Section 20(a) of the Securities Exchange Act of 1934, controlling executives may be held liable for failing to ensure the accuracy of company disclosures, with Meltzer and Daniel accused of not correcting misleading statements during their tenure, potentially leading to investor losses.
- Compliance Obligations: Both executives signed certifications under the Sarbanes-Oxley Act in Nano-X's 2024 annual report, yet the lawsuit claims these certifications were false at the time of signing, as they were allegedly aware of misalignments between production and demand, failing to fulfill their compliance responsibilities.
See More









